Elisa Vähäkangas

552 total citations
9 papers, 433 citations indexed

About

Elisa Vähäkangas is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Elisa Vähäkangas has authored 9 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Genetics and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Elisa Vähäkangas's work include Virus-based gene therapy research (6 papers), Nuclear Receptors and Signaling (2 papers) and RNA Interference and Gene Delivery (2 papers). Elisa Vähäkangas is often cited by papers focused on Virus-based gene therapy research (6 papers), Nuclear Receptors and Signaling (2 papers) and RNA Interference and Gene Delivery (2 papers). Elisa Vähäkangas collaborates with scholars based in Finland, Poland and Sweden. Elisa Vähäkangas's co-authors include Seppo Ylä‐Herttuala, Anna–Liisa Levonen, Jonna K. Koponen, Tuomas T. Rissanen, Petra Korpisalo, Agnieszka Jaźwa, Kari Alitalo, Johanna Lähteenvuo, Berndt Enholm and Ulf Eriksson and has published in prestigious journals such as Circulation, Molecular Therapy and Gene Therapy.

In The Last Decade

Elisa Vähäkangas

9 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisa Vähäkangas Finland 7 266 90 82 65 46 9 433
Luis Da Silva‐Azevedo Germany 12 254 1.0× 56 0.6× 36 0.4× 65 1.0× 17 0.4× 13 449
Ilana Talior‐Volodarsky Canada 10 237 0.9× 149 1.7× 30 0.4× 77 1.2× 24 0.5× 12 448
Jiana Huang China 11 325 1.2× 78 0.9× 25 0.3× 55 0.8× 21 0.5× 33 578
Rodney S. Kawahara United States 10 361 1.4× 49 0.5× 79 1.0× 21 0.3× 23 0.5× 18 635
Omar Akhouayri Canada 12 214 0.8× 38 0.4× 42 0.5× 31 0.5× 35 0.8× 25 462
Eneda Hoxha United States 7 244 0.9× 72 0.8× 16 0.2× 136 2.1× 21 0.5× 11 426
Anna Forslöw Sweden 10 146 0.5× 62 0.7× 21 0.3× 31 0.5× 22 0.5× 10 329
Tamami Nakamura Japan 11 181 0.7× 82 0.9× 12 0.1× 40 0.6× 28 0.6× 18 357
Maria-Grazia Spiga United States 8 258 1.0× 55 0.6× 27 0.3× 39 0.6× 45 1.0× 8 477
Shinji Tsuchida Japan 15 207 0.8× 90 1.0× 33 0.4× 18 0.3× 14 0.3× 48 503

Countries citing papers authored by Elisa Vähäkangas

Since Specialization
Citations

This map shows the geographic impact of Elisa Vähäkangas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Vähäkangas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Vähäkangas more than expected).

Fields of papers citing papers by Elisa Vähäkangas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Vähäkangas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Vähäkangas. The network helps show where Elisa Vähäkangas may publish in the future.

Co-authorship network of co-authors of Elisa Vähäkangas

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Vähäkangas. A scholar is included among the top collaborators of Elisa Vähäkangas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Vähäkangas. Elisa Vähäkangas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Karvinen, Henna, Tuomas T. Rissanen, Petra Korpisalo, et al.. (2011). Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle. Gene Therapy. 18(12). 1166–1172. 67 indexed citations
2.
Jaźwa, Agnieszka, Paulina Kucharzewska, Justyna Leja, et al.. (2010). Combined vascular endothelial growth factor-A and fibroblast growth factor 4 gene transfer improves wound healing in diabetic mice. PubMed. 8(1). 6–6. 51 indexed citations
3.
5.
Levonen, Anna–Liisa, Elisa Vähäkangas, Jonna K. Koponen, & Seppo Ylä‐Herttuala. (2008). Antioxidant Gene Therapy for Cardiovascular Disease. Circulation. 117(16). 2142–2150. 89 indexed citations
6.
Lehmusvaara, Saara, Tuula Salonen, Tanja Hakkarainen, et al.. (2006). Type I interferon response against viral and non‐viral gene transfer in human tumor and primary cell lines. The Journal of Gene Medicine. 9(2). 122–135. 17 indexed citations
7.
Vähäkangas, Elisa & Seppo Ylä‐Herttuala. (2005). Gene Therapy of Atherosclerosis. Handbook of experimental pharmacology. 785–807. 2 indexed citations
8.
Vähäkangas, Elisa, Robert A. Marr, Timo Pakkanen, et al.. (2004). Long-Term Lowering of Plasma Cholesterol Levels in LDL-Receptor-Deficient WHHL Rabbits by Gene Therapy. Molecular Therapy. 9(4). 548–556. 34 indexed citations
9.
Leppänen, Pia, Katri Pajusola, Outi Närvänen, et al.. (2003). Adeno-associated virus-mediated gene transfer of a secreted decoy human macrophage scavenger receptor reduces atherosclerotic lesion formation in LDL receptor knockout mice. Molecular Therapy. 8(6). 903–910. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026